ASA NJ Chapter 40th Annual Spring Symposium (SLIDES)
The New Jersey Chapter of the ASA held its 40th Annual Spring Symposium on June 28, 2019.
Theme: Clinical Trials for Rare Diseases and Pediatric Populations - Challenges in Design and Analysis
Click each title below for the presentation slides:
Cong Chen (Executive Director, Merck),
Statistical Considerations on Early-to-Late Transition of Oncology Projects
Peter Mesenbrink (Executive Director, Novartis),
Innovation in Pediatric Trial Design in Rare Autoimmune Diseases
Hui Quan (Associate VP, Sanofi),
A Case Study of Phase II/III Seamless Adaptive Design in a Rare Disease Area
Gary Rosner (Professor, Johns Hopkins University),
Meta-Analysis of Rare Adverse Events in Randomized Clinical Trials: Bayesian and Frequentist
Methods
Satrajit Roychoudhury (Senior Director, Pfizer),
Incorporating Adult Clinical Data into Pediatric Clinical Trials: A Robust Bayesian
Approach
James Travis (Mathematical Statistician, FDA),
Pediatric Drug Development – A Regulatory Perspective
